IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $288,014 | -98.4% | 29,908 | -98.2% | 0.00% | -97.4% |
| Q2 2023 | $17,960,458 | +79.6% | 1,688,013 | +77.5% | 0.04% | +56.0% |
| Q1 2023 | $10,001,743 | +629.0% | 950,736 | +699.1% | 0.02% | +525.0% |
| Q2 2022 | $1,372,000 | +319.6% | 118,980 | +275.7% | 0.00% | +33.3% |
| Q2 2020 | $327,000 | +153.5% | 31,670 | +147.7% | 0.00% | +50.0% |
| Q1 2020 | $129,000 | -43.2% | 12,787 | -38.4% | 0.00% | +100.0% |
| Q2 2019 | $227,000 | +29.7% | 20,747 | +60.5% | 0.00% | 0.0% |
| Q1 2019 | $175,000 | -42.2% | 12,926 | -55.7% | 0.00% | -50.0% |
| Q4 2018 | $303,000 | -9.0% | 29,207 | +67.7% | 0.00% | 0.0% |
| Q2 2018 | $333,000 | +57.8% | 17,412 | +27.4% | 0.00% | +100.0% |
| Q1 2018 | $211,000 | – | 13,672 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |